ITPKB suppresses ER calcium release to promote CXCL9 expression and enhance immunotherapy sensitivity in triple-negative breast cancer

Drug Resistance Updates · Published 2026-08-02 · DOI 10.1016/j.drup.2026.101467

Authors (15)

Kejing Zhang, Xia Wang, Qiaoli Yi, Huajie Guan, Jiayu Wang, Fengyu Tan, Zhiyang Zhou, Xudong Zhu, Cheng Zhan, Jin Wang, Jianmin Wu, Hailin Tang, Zhijie Xu, Zeyu Shuang, Yuanliang Yan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Zhang, K., Wang, X., Yi, Q., et al. (2026). ITPKB suppresses ER calcium release to promote CXCL9 expression and enhance immunotherapy sensitivity in triple-negative breast cancer. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2026.101467

Related articles